Montelukast offers "comparable asthma control" in paediatric patients

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1577, 2007-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Montelukast reduces eosinophilic inflammation in patients with asthma

Inpharma, Vol. 1, Iss. 1335, 2002-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Montelukast Decreases Plasma Endothelin-1 and Serum Eosinophil Cationic Protein Levels in Paediatric Atopic Asthma

By Kopřiva Frantisek

Clinical Drug Investigation, Vol. 26, Iss. 6, 2006-01 ,pp. : 351-356

Adis International

Access to resources Recommend Favorite

Fexofenadine/pseudoephedrine comparable to loratadine/montelukast combo

Inpharma, Vol. 1, Iss. 1424, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Fexofenadine/pseudoephedrine comparable to loratadine/montelukast combo

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 446, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Montelukast in children with asthma - new evidence

Inpharma, Vol. 1, Iss. 1260, 2000-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite